dementia, cholesterol and Alzheimer's disease

Digest more
Low 'bad' cholesterol might protect against dementia, Alzheimer's disease
Lower levels of "bad" LDL cholesterol could mean a lower risk of dementia and Alzheimer's disease, a new study says.
Maintaining low cholesterol may help decrease dementia risk
Now, a study has found that low levels of LDL-C, or ‘bad’ cholesterol, may reduce the risk of developing dementia. Statins, a cholesterol-lowering medication, could reduce the risk of dementia further in people with low LDL-C.
Shingles Vaccination May Help Protect People from Alzheimer’s Disease
The findings suggest that the shingles virus might play a role in causing at least a subset of dementia cases, Geldsetzer says, and the vaccine may protect against that. Alternatively, it could be that certain vaccines, such as the one for shingles, lead to a broader immune system activation that lowers the risk of dementia developing.

New blood test diagnoses Alzheimer's disease

Digest more
New blood test diagnoses Alzheimer’s disease and measures how far it's progressed
A new blood test test could determine how far Alzheimer's has progressed and could also help confirm whether another condition is causing a person’s cognitive symptoms.
A new blood test could improve how Alzheimer’s disease is diagnosed
The blood test for eMTBR-tau243 shows strong correlation with tau pathology, enhancing Alzheimer's diagnosis and monitoring cognitive decline effectively.
Scientists Develop Blood Test That Diagnoses Alzheimer’s And Identifies What Stage It Has Reached
Scientists have developed a blood test for Alzheimer’s disease that can help diagnose the neurodegenerative disease while also indicating how far it has progressed. The results could help doctors decide which medications to prescribe depending on how long they’ve had the condition.
PhillyVoice1h
Shingles vaccine may lower dementia risk by 20% in older adults, study shows
With new dementia cases expected to double in the United States by 2060, the therapy could be a difference maker. But ...
Biogen’s tau targeting Alzheimer’s disease therapy gets FDA Fast Track status
Biogen (NASDAQ:BIIB) said on Wednesday that the U.S. FDA has granted Fast Track designation to BIIB080, its antisense ...
Getting this vaccine lowered seniors’ dementia risk by 20%
A new study out of Stanford has presented the strongest evidence to date that a common vaccine could significantly reduce the ...
Shingles is awful, but here’s another reason to get vaccinated: It may fight dementia
A vaccination to prevent horribly painful shingles may offer an extra benefit: New research suggests it might lower the risk ...
KALW5h
Latest Alzheimer's lab tests focus on memory loss, not brain plaques
Worley was part of a team that showed how the loss of one of the two proteins used in the test disrupts synapses and leads to ...
NOLA.com5d
Explaining Alzheimer's to a child could be ongoing process. Allow open talks about disease
The explanation of Alzheimer's, given the span of the disease, could become more of an ongoing process for the child rather ...
Explore more
MPR4h
Tau-Targeting Antisense Therapy for Alzheimer Disease Gets Fast Track Status
BIIB080 is an antisense oligonucleotide therapy designed to target microtubule-associated protein tau mRNA and reduce the production of tau.
News-Medical.Net on MSN4h
New drug shows neuroprotective and anti-inflammatory effects in murine models of Alzheimer's
Alzheimer's disease, the most common cause of dementia, is currently incurable. The current drugs available have very limited ...